310 related articles for article (PubMed ID: 15824169)
1. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.
Rennert H; Zeigler-Johnson CM; Addya K; Finley MJ; Walker AH; Spangler E; Leonard DG; Wein A; Malkowicz SB; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):949-57. PubMed ID: 15824169
[TBL] [Abstract][Full Text] [Related]
2. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.
Nupponen NN; Wallén MJ; Ponciano D; Robbins CM; Tammela TL; Vessella RL; Carpten JD; Visakorpi T
Genes Chromosomes Cancer; 2004 Feb; 39(2):119-25. PubMed ID: 14695991
[TBL] [Abstract][Full Text] [Related]
4. Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
Robbins CM; Hernandez W; Ahaghotu C; Bennett J; Hoke G; Mason T; Pettaway CA; Vijayakumar S; Weinrich S; Furbert-Harris P; Dunston G; Powell IJ; Carpten JD; Kittles RA
Prostate; 2008 Dec; 68(16):1790-7. PubMed ID: 18767027
[TBL] [Abstract][Full Text] [Related]
5. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.
Alvarez-Cubero MJ; Pascual-Geler M; Martinez-Gonzalez LJ; Expósito Ruiz M; Saiz M; Cozar JM; Lorente JA
Urol Oncol; 2016 Oct; 34(10):431.e1-8. PubMed ID: 27318894
[TBL] [Abstract][Full Text] [Related]
6. Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
Noonan-Wheeler FC; Wu W; Roehl KA; Klim A; Haugen J; Suarez BK; Kibel AS
Prostate; 2006 Jan; 66(1):49-56. PubMed ID: 16114055
[TBL] [Abstract][Full Text] [Related]
7. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer.
Rennert H; Zeigler-Johnson C; Mittal RD; Tan YC; Sadowl CM; Edwards J; Finley MJ; Mandhani A; Mital B; Rebbeck TR
Urology; 2008 Aug; 72(2):456-60. PubMed ID: 18436282
[TBL] [Abstract][Full Text] [Related]
9. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.
Maier C; Haeusler J; Herkommer K; Vesovic Z; Hoegel J; Vogel W; Paiss T
Br J Cancer; 2005 Mar; 92(6):1159-64. PubMed ID: 15714208
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of genetic biomarkers in clinical progression of prostate cancer.
Alvarez-Cubero MJ; Martinez-Gonzalez LJ; Saiz M; Carmona-Saez P; Alvarez JC; Pascual-Geler M; Lorente JA; Cozar JM
Exp Mol Med; 2015 Aug; 47(8):e176. PubMed ID: 26251261
[TBL] [Abstract][Full Text] [Related]
11. MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China.
Hsing AW; Sakoda LC; Chen J; Chokkalingam AP; Sesterhenn I; Gao YT; Xu J; Zheng SL
Carcinogenesis; 2007 Dec; 28(12):2530-6. PubMed ID: 17768178
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk.
Xu J; Zheng SL; Komiya A; Mychaleckyj JC; Isaacs SD; Hu JJ; Sterling D; Lange EM; Hawkins GA; Turner A; Ewing CM; Faith DA; Johnson JR; Suzuki H; Bujnovszky P; Wiley KE; DeMarzo AM; Bova GS; Chang B; Hall MC; McCullough DL; Partin AW; Kassabian VS; Carpten JD; Bailey-Wilson JE; Trent JM; Ohar J; Bleecker ER; Walsh PC; Isaacs WB; Meyers DA
Nat Genet; 2002 Oct; 32(2):321-5. PubMed ID: 12244320
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.
Xu J; Zheng SL; Carpten JD; Nupponen NN; Robbins CM; Mestre J; Moses TY; Faith DA; Kelly BD; Isaacs SD; Wiley KE; Ewing CM; Bujnovszky P; Chang B; Bailey-Wilson J; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Am J Hum Genet; 2001 Apr; 68(4):901-11. PubMed ID: 11254448
[TBL] [Abstract][Full Text] [Related]
14. RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.
Wei B; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Yan Z; Xuan F; Zhou H; Huang X; Zhang J; Lu P; Shao J
Mol Biol Rep; 2012 Mar; 39(3):2347-53. PubMed ID: 21656378
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of the principal genes related to prostate cancer: a review.
Alvarez-Cubero MJ; Saiz M; Martinez-Gonzalez LJ; Alvarez JC; Lorente JA; Cozar JM
Urol Oncol; 2013 Nov; 31(8):1419-29. PubMed ID: 23141781
[TBL] [Abstract][Full Text] [Related]
16. RNASEL germline variants are associated with pancreatic cancer.
Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
[TBL] [Abstract][Full Text] [Related]
17. Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men.
Miller DC; Zheng SL; Dunn RL; Sarma AV; Montie JE; Lange EM; Meyers DA; Xu J; Cooney KA
Cancer Res; 2003 Jul; 63(13):3486-9. PubMed ID: 12839931
[TBL] [Abstract][Full Text] [Related]
18. RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.
Daugherty SE; Hayes RB; Yeager M; Andriole GL; Chatterjee N; Huang WY; Isaacs WB; Platz EA
Prostate; 2007 Jun; 67(8):849-54. PubMed ID: 17407163
[TBL] [Abstract][Full Text] [Related]
19. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.
Agalliu I; Leanza SM; Smith L; Trent JM; Carpten JD; Bailey-Wilson JE; Burk RD
Prostate; 2010 Nov; 70(15):1716-27. PubMed ID: 20564318
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer susceptibility genes: lessons learned and challenges posed.
Simard J; Dumont M; Labuda D; Sinnett D; Meloche C; El-Alfy M; Berger L; Lees E; Labrie F; Tavtigian SV
Endocr Relat Cancer; 2003 Jun; 10(2):225-59. PubMed ID: 12790786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
